A carregar...
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) is a devastating disease hallmarked by limited patient survival. Resistance to chemotherapy, a major cause of treatment failure in PDAC patients, is often attributed to Cancer Stem Cells (CSCs). Pancreatic CSCs are a small subset of quiescent cells...
Na minha lista:
| Publicado no: | Mol Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4657383/ https://ncbi.nlm.nih.gov/pubmed/26597727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0470-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|